Eli Lilly and Company (FRA:LLY)
704.20
+2.70 (0.38%)
At close: Oct 23, 2025
Eli Lilly and Company Employees
Eli Lilly and Company had 47,000 employees as of December 31, 2024. The number of employees increased by 4,000 or 9.30% compared to the previous year.
Employees
47,000
Change (1Y)
4,000
Growth (1Y)
9.30%
Revenue / Employee
€964,878
Profits / Employee
€250,013
Market Cap
628.11B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 47,000 | 4,000 | 9.30% |
| Dec 31, 2023 | 43,000 | 4,000 | 10.26% |
| Dec 31, 2022 | 39,000 | 4,000 | 11.43% |
| Dec 31, 2021 | 35,000 | 0 | - |
| Dec 31, 2020 | 35,000 | 1,375 | 4.09% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Siemens Aktiengesellschaft | 327,000 |
| Deutsche Telekom AG | 198,194 |
| Mercedes-Benz Group AG | 175,264 |
| Allianz SE | 156,626 |
| SAP SE | 109,121 |
| Siemens Energy AG | 98,000 |
| Deutsche Bank Aktiengesellschaft | 89,753 |
| Siemens Healthineers AG | 72,000 |
Eli Lilly and Company News
- 11 hours ago - Lilly and Cipla tie up to broaden access of weight-loss therapy - The Times of India
- 13 hours ago - 10 stocks primed for growth in the S&P 500's cheapest sectors - Market Watch
- 14 hours ago - Eli Lilly (LLY) Partners with Cipla to Market Tirzepatide in India - GuruFocus
- 17 hours ago - Eli Lilly Accelerates On Obesity Data While Novo Nordisk Retreats - Seeking Alpha
- 18 hours ago - Eli Lilly allows Cipla to sell weight loss drug under new brand in India - Reuters
- 1 day ago - Why Is Terns Pharmaceuticals Stock Trading Lower After Obesity Trial Data? - Benzinga
- 1 day ago - 3 Things Investors Need to Know Ahead of Eli Lilly's Q3 Earnings Report - The Motley Fool
- 2 days ago - Notable Tuesday Option Activity: LUV, TMO, LLY - Nasdaq